Cargando…

Taurine regulates insulin release from pancreatic beta cell lines

BACKGROUND: Pancreatic β-cells release insulin via an electrogenic response triggered by an increase in plasma glucose concentrations. The critical plasma glucose concentration has been determined to be ~3 mM, at which time both insulin and GABA are released from pancreatic β-cells. Taurine, a β-sul...

Descripción completa

Detalles Bibliográficos
Autores principales: L’Amoreaux, William J, Cuttitta, Christina, Santora, Allison, Blaize, Jonathan F, Tachjadi, Janto, El Idrissi, Abdeslem
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994409/
https://www.ncbi.nlm.nih.gov/pubmed/20804585
http://dx.doi.org/10.1186/1423-0127-17-S1-S11
_version_ 1782192933257084928
author L’Amoreaux, William J
Cuttitta, Christina
Santora, Allison
Blaize, Jonathan F
Tachjadi, Janto
El Idrissi, Abdeslem
author_facet L’Amoreaux, William J
Cuttitta, Christina
Santora, Allison
Blaize, Jonathan F
Tachjadi, Janto
El Idrissi, Abdeslem
author_sort L’Amoreaux, William J
collection PubMed
description BACKGROUND: Pancreatic β-cells release insulin via an electrogenic response triggered by an increase in plasma glucose concentrations. The critical plasma glucose concentration has been determined to be ~3 mM, at which time both insulin and GABA are released from pancreatic β-cells. Taurine, a β-sulfonic acid, may be transported into cells to balance osmotic pressure. The taurine transporter (TauT) has been described in pancreatic tissue, but the function of taurine in insulin release has not been established. Uptake of taurine by pancreatic β-cells may alter membrane potential and have an effect on ion currents. If taurine uptake does alter β-cell current, it might have an effect on exocytosis of cytoplasmic vesicle. We wished to test the effect of taurine on regulating release of insulin from the pancreatic β-cell. METHODS: Pancreatic β-cell lines Hit-TI5 (Syrian hamster) and Rin-m (rat insulinoma) were used in these studies. Cells were grown to an 80% confluence on uncoated cover glass in RPMI media containing 10% fetal horse serum. The cells were then adapted to a serum-free, glucose free environment for 24 hours. At that time, the cells were treated with either 1 mM glucose, 1 mM taurine, 1 mM glucose + 1 mM taurine, 3 mM glucose, or 3 mM glucose + 1 mM taurine. The cells were examined by confocal microscopy for cytoplasmic levels of insulin. RESULTS: In both cell lines, 1 mM glucose had no effect on insulin levels and served as a control. Cells starved of glucose had a significant reduction (p<0.001) in the level of insulin, but this level was significantly higher than all other treatments. As expected, the 3 mM glucose treatment resulted in a statistically lower (p<0.001) insulin level than control cells. Interestingly, 1 mM taurine also resulted in a statistically lower level of insulin (p<0.001) compared to controls when either no glucose or 1 mM glucose was present. Cells treated with 1 mM taurine plus 3 mM glucose showed a level of insulin similar to that of 3 mM glucose alone. CONCLUSIONS: Taurine administration can alter the electrogenic response in β-cell lines, leading to a change in calcium homeostasis and a subsequent decrease in intracellular insulin levels. The consequence of these actions could represent a method of increasing plasma insulin levels leading to a decrease in plasma glucose levels.
format Text
id pubmed-2994409
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29944092010-12-01 Taurine regulates insulin release from pancreatic beta cell lines L’Amoreaux, William J Cuttitta, Christina Santora, Allison Blaize, Jonathan F Tachjadi, Janto El Idrissi, Abdeslem J Biomed Sci Review BACKGROUND: Pancreatic β-cells release insulin via an electrogenic response triggered by an increase in plasma glucose concentrations. The critical plasma glucose concentration has been determined to be ~3 mM, at which time both insulin and GABA are released from pancreatic β-cells. Taurine, a β-sulfonic acid, may be transported into cells to balance osmotic pressure. The taurine transporter (TauT) has been described in pancreatic tissue, but the function of taurine in insulin release has not been established. Uptake of taurine by pancreatic β-cells may alter membrane potential and have an effect on ion currents. If taurine uptake does alter β-cell current, it might have an effect on exocytosis of cytoplasmic vesicle. We wished to test the effect of taurine on regulating release of insulin from the pancreatic β-cell. METHODS: Pancreatic β-cell lines Hit-TI5 (Syrian hamster) and Rin-m (rat insulinoma) were used in these studies. Cells were grown to an 80% confluence on uncoated cover glass in RPMI media containing 10% fetal horse serum. The cells were then adapted to a serum-free, glucose free environment for 24 hours. At that time, the cells were treated with either 1 mM glucose, 1 mM taurine, 1 mM glucose + 1 mM taurine, 3 mM glucose, or 3 mM glucose + 1 mM taurine. The cells were examined by confocal microscopy for cytoplasmic levels of insulin. RESULTS: In both cell lines, 1 mM glucose had no effect on insulin levels and served as a control. Cells starved of glucose had a significant reduction (p<0.001) in the level of insulin, but this level was significantly higher than all other treatments. As expected, the 3 mM glucose treatment resulted in a statistically lower (p<0.001) insulin level than control cells. Interestingly, 1 mM taurine also resulted in a statistically lower level of insulin (p<0.001) compared to controls when either no glucose or 1 mM glucose was present. Cells treated with 1 mM taurine plus 3 mM glucose showed a level of insulin similar to that of 3 mM glucose alone. CONCLUSIONS: Taurine administration can alter the electrogenic response in β-cell lines, leading to a change in calcium homeostasis and a subsequent decrease in intracellular insulin levels. The consequence of these actions could represent a method of increasing plasma insulin levels leading to a decrease in plasma glucose levels. BioMed Central 2010-08-24 /pmc/articles/PMC2994409/ /pubmed/20804585 http://dx.doi.org/10.1186/1423-0127-17-S1-S11 Text en Copyright ©2010 L’Amoreaux et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
L’Amoreaux, William J
Cuttitta, Christina
Santora, Allison
Blaize, Jonathan F
Tachjadi, Janto
El Idrissi, Abdeslem
Taurine regulates insulin release from pancreatic beta cell lines
title Taurine regulates insulin release from pancreatic beta cell lines
title_full Taurine regulates insulin release from pancreatic beta cell lines
title_fullStr Taurine regulates insulin release from pancreatic beta cell lines
title_full_unstemmed Taurine regulates insulin release from pancreatic beta cell lines
title_short Taurine regulates insulin release from pancreatic beta cell lines
title_sort taurine regulates insulin release from pancreatic beta cell lines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994409/
https://www.ncbi.nlm.nih.gov/pubmed/20804585
http://dx.doi.org/10.1186/1423-0127-17-S1-S11
work_keys_str_mv AT lamoreauxwilliamj taurineregulatesinsulinreleasefrompancreaticbetacelllines
AT cuttittachristina taurineregulatesinsulinreleasefrompancreaticbetacelllines
AT santoraallison taurineregulatesinsulinreleasefrompancreaticbetacelllines
AT blaizejonathanf taurineregulatesinsulinreleasefrompancreaticbetacelllines
AT tachjadijanto taurineregulatesinsulinreleasefrompancreaticbetacelllines
AT elidrissiabdeslem taurineregulatesinsulinreleasefrompancreaticbetacelllines